vs
Side-by-side financial comparison of CapsoVision, Inc (CV) and D-Wave Quantum Inc. (QBTS). Click either name above to swap in a different company.
CapsoVision, Inc is the larger business by last-quarter revenue ($3.5M vs $2.8M, roughly 1.3× D-Wave Quantum Inc.). CapsoVision, Inc runs the higher net margin — -223.9% vs -1538.0%, a 1314.1% gap on every dollar of revenue. CapsoVision, Inc produced more free cash flow last quarter ($-5.7M vs $-20.0M).
CapsoVision, Inc. is a medical technology firm specializing in the development and manufacturing of advanced capsule endoscopy systems and supporting diagnostic solutions. Its non-invasive gastrointestinal imaging products are supplied to hospitals, gastroenterology clinics and medical specialists across global markets, supporting more accurate detection of digestive diseases and improved patient care experiences.
D-Wave Quantum Inc. is a quantum computing company with locations in Palo Alto, California and Burnaby, British Columbia. D-Wave claims to be the world's first company to sell computers that exploit quantum effects in their operation. D-Wave's early customers include Lockheed Martin, the University of Southern California, Google/NASA, and Los Alamos National Laboratory.
CV vs QBTS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.5M | $2.8M |
| Net Profit | $-7.9M | $-42.3M |
| Gross Margin | 54.1% | 64.8% |
| Operating Margin | -226.7% | -1266.0% |
| Net Margin | -223.9% | -1538.0% |
| Revenue YoY | — | 19.2% |
| Net Profit YoY | — | 50.8% |
| EPS (diluted) | $-0.17 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.8M | ||
| Q3 25 | $3.5M | $3.7M | ||
| Q2 25 | $3.3M | $3.1M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $2.3M | ||
| Q2 24 | — | $2.2M | ||
| Q1 24 | — | $2.5M | ||
| Q4 23 | — | $2.9M |
| Q4 25 | — | $-42.3M | ||
| Q3 25 | $-7.9M | $-140.0M | ||
| Q2 25 | $-4.6M | $-167.3M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $-86.1M | ||
| Q2 24 | — | $-17.8M | ||
| Q1 24 | — | $-17.3M | ||
| Q4 23 | — | $-16.0M |
| Q4 25 | — | 64.8% | ||
| Q3 25 | 54.1% | 71.4% | ||
| Q2 25 | 54.6% | 63.8% | ||
| Q1 25 | — | 92.5% | ||
| Q4 24 | — | 63.8% | ||
| Q2 24 | — | 63.6% | ||
| Q1 24 | — | 67.3% | ||
| Q4 23 | — | 67.7% |
| Q4 25 | — | -1266.0% | ||
| Q3 25 | -226.7% | -741.8% | ||
| Q2 25 | -140.3% | -856.3% | ||
| Q1 25 | — | -75.3% | ||
| Q4 24 | — | -876.2% | ||
| Q2 24 | — | -863.0% | ||
| Q1 24 | — | -710.6% | ||
| Q4 23 | — | -569.2% |
| Q4 25 | — | -1538.0% | ||
| Q3 25 | -223.9% | -3743.9% | ||
| Q2 25 | -139.5% | -5406.4% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | — | -3727.9% | ||
| Q2 24 | — | -814.4% | ||
| Q1 24 | — | -702.3% | ||
| Q4 23 | — | -551.1% |
| Q4 25 | — | $-0.13 | ||
| Q3 25 | $-0.17 | $-0.41 | ||
| Q2 25 | $-2.02 | $-0.55 | ||
| Q1 25 | — | $-0.02 | ||
| Q4 24 | — | $-0.43 | ||
| Q2 24 | — | $-0.10 | ||
| Q1 24 | — | $-0.11 | ||
| Q4 23 | — | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $884.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $20.4M | $852.2M |
| Total Assets | $25.7M | $915.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $884.5M | ||
| Q3 25 | — | $836.2M | ||
| Q2 25 | — | $819.3M | ||
| Q1 25 | — | $304.3M | ||
| Q4 24 | — | $178.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $41.3M |
| Q4 25 | — | $852.2M | ||
| Q3 25 | $20.4M | $670.6M | ||
| Q2 25 | $-139.0M | $694.3M | ||
| Q1 25 | — | $207.4M | ||
| Q4 24 | — | $62.6M | ||
| Q2 24 | — | $-21.5M | ||
| Q1 24 | — | $-37.0M | ||
| Q4 23 | — | $-24.5M |
| Q4 25 | — | $915.8M | ||
| Q3 25 | $25.7M | $865.8M | ||
| Q2 25 | $9.5M | $843.6M | ||
| Q1 25 | — | $325.6M | ||
| Q4 24 | — | $199.9M | ||
| Q2 24 | — | $61.8M | ||
| Q1 24 | — | $48.6M | ||
| Q4 23 | — | $59.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.7M | $-18.4M |
| Free Cash FlowOCF − Capex | $-5.7M | $-20.0M |
| FCF MarginFCF / Revenue | -160.5% | -727.9% |
| Capex IntensityCapex / Revenue | 0.3% | 60.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-75.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-18.4M | ||
| Q3 25 | $-5.7M | $-19.0M | ||
| Q2 25 | $-9.5M | $-15.3M | ||
| Q1 25 | — | $-19.3M | ||
| Q4 24 | — | $2.0M | ||
| Q2 24 | — | $-14.5M | ||
| Q1 24 | — | $-12.1M | ||
| Q4 23 | — | $-14.7M |
| Q4 25 | — | $-20.0M | ||
| Q3 25 | $-5.7M | $-20.1M | ||
| Q2 25 | $-9.6M | $-16.0M | ||
| Q1 25 | — | $-19.7M | ||
| Q4 24 | — | $1.1M | ||
| Q2 24 | — | $-15.0M | ||
| Q1 24 | — | $-12.4M | ||
| Q4 23 | — | $-15.2M |
| Q4 25 | — | -727.9% | ||
| Q3 25 | -160.5% | -536.5% | ||
| Q2 25 | -289.0% | -518.1% | ||
| Q1 25 | — | -131.4% | ||
| Q4 24 | — | 46.2% | ||
| Q2 24 | — | -687.7% | ||
| Q1 24 | — | -504.0% | ||
| Q4 23 | — | -522.4% |
| Q4 25 | — | 60.3% | ||
| Q3 25 | 0.3% | 27.2% | ||
| Q2 25 | 2.1% | 24.2% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 41.1% | ||
| Q2 24 | — | 25.0% | ||
| Q1 24 | — | 12.4% | ||
| Q4 23 | — | 15.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CV
| Products | $2.5M | 71% |
| Other | $1.0M | 29% |
QBTS
| Transferred Over Time | $2.4M | 89% |
| Other | $306.0K | 11% |
